Jin Medical International (ZJYL) Receivables (2022 - 2025)

Jin Medical International has disclosed Receivables across 4 years of filings, most recently posting $6.1 million for Q3 2025.

• Receivables for Q3 2025 came in at $6.1 million, down 67.67% year-over-year; the trailing twelve-month figure through Sep 2025 was $6.1 million (down 67.67% YoY), and the FY2025 annual result was $6.1 million, down 67.67% from the prior year.
• Receivables came in at $6.1 million for Q3 2025 at Jin Medical International, up from $4.4 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $18.9 million in Q3 2024 to a low of $3.9 million in Q1 2024.
• The 4-year median for Receivables is $6.1 million (2025), against an average of $7.7 million.
• Across the five-year window, Receivables surged 147.15% in 2024 and sank 67.67% in 2025, its largest moves.
• Jin Medical International's Receivables stood at $4.0 million in 2022, then jumped by 93.05% to $7.6 million in 2023, then soared by 147.15% to $18.9 million in 2024, then tumbled by 67.67% to $6.1 million in 2025.
• The last three Receivables figures came in at $6.1 million (Q3 2025), $4.4 million (Q1 2025), and $18.9 million (Q3 2024), per Business Quant data.